je.st
news
Home
› Cellular Dynamics Announces Agreement With AstraZeneca On Use Of iPSC-Derived Human Cells In Drug Discovery Research
Cellular Dynamics Announces Agreement With AstraZeneca On Use Of iPSC-Derived Human Cells In Drug Discovery Research
2013-01-07 07:29:27| drugdiscoveryonline News Articles
Cellular Dynamics International, Inc. (CDI) recently announced a Center of Excellence agreement with AstraZeneca to accelerate the pace of drug discovery through the use of human induced pluripotent stem cell (iPSC) lines and tissue cells.
Tags: research
agreement
human
drug
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||